Latest Breaking News On - Primary advanced endometrial - Page 1 : comparemela.com

In the RUBY phase 3 trial, dostarlimab (Jemperli; GSK) with niraparib (Zejula; GSK) had significant progression free survival compared to the standard of care.

Dostarlimab jemperliHesham abdullahNational library of medicineSociety of gynecologic oncologyTesaro incDesign cellsGynecologic oncologyNational libraryUnited stateParticipants with recurrentPrimary advanced endometrial